Differentiation of HL-60 cells to granulocytes involves regulation of select diacylglycerol kinases (DGKs).
Diacylglycerol Kinases (DGKs) are a family of enzymes that regulate the levels of different pools of diacylglycerol (DAG), affecting DAG-mediated signal transduction. Since DAG is known to play several important regulatory roles in granulocyte physiology, we investigated the expression pattern of DGK isoforms throughout differentiation of HL-60 cells to granulocytes. HL-60 cells were incubated with 1.25% dimethyl-sulfoxide (DMSO) to initiate differentiation and total RNA isolated at different time points. DGK expression was assessed through Northern blot, end-point PCR, and real-time PCR. The non-selective inhibitors R59022 and R59949 were used to block DGK at different time points throughout differentiation. CD11b and GPI-80, reactive oxygen species (ROS) generation, changes in the cell cycle, and apoptosis were used as markers of differentiation. Of the nine isoforms of DGK evaluated (alpha, delta, epsilon, gamma, zeta, beta, theta;, iota, eta), only five (alpha, delta, epsilon, gamma, and zeta) were expressed in HL-60 cells. DGKalpha was virtually absent in non-differentiated cells, but was markedly upregulated throughout differentiation. The other isoforms (delta, epsilon, gamma, and zeta) were expressed in undifferentiated HL-60 cells but were substantially decreased throughout differentiation. Non-selective blocking of DGK with R59022 and R59949 led to acceleration of differentiation, reducing the time necessary to observe upregulation of CD11b, GPI-80 and generation of ROS by 50%. Likewise, the cell cycle was disrupted when DGK isoforms were inhibited. These results provide evidence that DGK levels are dynamically regulated throughout differentiation and that expression of DGKs play an important regulatory function during the differentiation of neutrophils.
Batista
Eraldo L
EL
Department of Oral Biology and Periodontology, Goldman School of Dental Medicine, Boston University, Boston, MA 02118, USA.
Warbington
Martha
M
Badwey
John A
JA
Van Dyke
Thomas E
TE
D000581:Amidohydrolases; D017209:Apoptosis; D018845:CD11 Antigens / Q000378:metabolism; D015815:Cell Adhesion Molecules / Q000378:metabolism; D002454:Cell Differentiation / Q000187:drug effects; D019852:Diacylglycerol Kinase / Q000235:genetics / Q000378:metabolism*; D004121:Dimethyl Sulfoxide / Q000494:pharmacology; D058851:GPI-Linked Proteins; D006098:Granulocytes / Q000166:cytology* / Q000187:drug effects / Q000201:enzymology*; D018922:HL-60 Cells; D006801:Humans; D006867:Hydrolases; D007527:Isoenzymes / Q000235:genetics / Q000378:metabolism; D047428:Protein Kinase Inhibitors / Q000494:pharmacology; D011744:Pyrimidinones / Q000494:pharmacology; D012333:RNA, Messenger / Q000235:genetics; D017382:Reactive Oxygen Species / Q000378:metabolism; D013844:Thiazoles / Q000494:pharmacology
D018845:CD11 Antigens; D015815:Cell Adhesion Molecules; D058851:GPI-Linked Proteins; D007527:Isoenzymes; D047428:Protein Kinase Inhibitors; D011744:Pyrimidinones; D012333:RNA, Messenger; D017382:Reactive Oxygen Species; D013844:Thiazoles; C047505:R 59022; D019852:Diacylglycerol Kinase; D006867:Hydrolases; D000581:Amidohydrolases; C121771:VNN2 protein, human; D004121:Dimethyl Sulfoxide